生物藥學特論
Biopharmaceutical Sciences
| 節 | 週二 |
|---|---|
3 10:10–11:00 | 生物藥學特論 YC101（陽明） 2 節連堂 |
4 11:10–12:00 |
* 根據陽明交大上課時間表所列
教師未提供此項資料
教師未提供此項資料
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | 03/05 (Thur.) Metabolomics as the last OMICS; its potential and limitations in translational medicine 2 Dr. Ming-Shi Shiao 2020/03/03 |
| 第 2 週 | From prediabetes to T2DM and diabetic complications: what metabolomics can do 2020/03/10 |
| 第 3 週 | 03/12 (Thur.) Adoptive cell therapy and CAR-T 2 Dr. Jin-Hwang Liu 2020/03/17 |
| 第 4 週 | 03/17 Translational Medicine: An Overview 2 Sherry Ku 2020/03/24 |
| 第 5 週 | 3/19 (Thur,) Ageing and Cancer 2 Dr. Tsui-Ting Ching 2020/03/31 |
| 第 6 週 | 03/24 Companion Diagnostic for diseases 2 Chung-Fan Lee 2020/04/07 |
| 第 7 週 | 03/31 Challenges of a Botanical New Drug before Marketing 2 Dr. I-Ping Lin 2020/04/14 |
| 第 8 週 | 04/07 Drug development from lead compound to the early clinical phase 2 Hubert Chan 2020/04/21 |
| 第 9 週 | 04/14 Midterm and discussion Dr. Chi-Ying Huang 2020/04/28 |
| 第 10 週 | 04/21 Cancer Immunotherapy Past, current and future aspects Dr. Jan-Mou Lee 2020/05/05 |
| 第 11 週 | 04/28 The use of microbial nutraceuticals as alternative for pharmaceuticals 2 Jenny Li 2020/05/12 |
| 第 12 週 | 05/05 Biosimilars 2 Dr. Kevin S Wang 2020/05/19 |
| 第 13 週 | 05/12 Methodology for drug discovery: cell-based assay in pharmaceutical research Dr. Ying-Ta Wu 2020/05/26 |
| 第 14 週 | 05/19 Neurological diseases and pharmaceutical development strategy 2 Dr. Young-Ji Shiao 2020/06/02 |
| 第 15 週 | 05/26 Drug discovery via SAR Wen-Jin Yang 2020/06/09 |
| 第 16 週 | 06/02 Tumor initiating cells and pharmaceutical development strategy 2 Dr. Yeu Su 2020/06/16 |
| 第 17 週 | 06/09 Tumor microenvironment and druggable targets 2 Dr. Yeu Su 2020/06/23 |
| 第 18 週 | 06/16 Final exam and discussion 2 Dr. Chi-Ying Huang 2020/06/30 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料